An in-depth analysis of medication errors in hospitalized patients with HIV;Un análisis en profundo de los errores de medicación en pacientes hospitalizados con VIH

Annals of Pharmacotherapy

Volumn 45, Issue 4, 2011, Pages 459-468

  Snyder, Ann M ^a   Klinker, Kenneth ^b   Orrick, Joanne J ^c   Janelle, Jennifer ^c   Winterstein, Almut G ^b  

^a UNIVERSITY OF FLORIDA HEALTH   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Antiretroviral; HIV AIDS; Medication errors; Root cause

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; ATAZANAVIR; COTRIMOXAZOLE; EFAVIRENZ; FOSAMPRENAVIR; INDINAVIR; LOPINAVIR PLUS RITONAVIR; NELFINAVIR; NEVIRAPINE; STAVUDINE;

ADULT; ANTIVIRAL THERAPY; ARTICLE; BEDTIME DOSAGE; CLINICAL ARTICLE; DRUG OVERDOSE; DRUG UNDERDOSE; DRUG USE; FOOD DRUG INTERACTION; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDICAL RECORD REVIEW; MEDICATION ERROR; MORNING DOSAGE; OPPORTUNISTIC INFECTION; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-RETROVIRAL AGENTS; DRUG INTERACTIONS; DRUG PRESCRIPTIONS; HIV INFECTIONS; HOSPITALIZATION; HUMANS; INAPPROPRIATE PRESCRIBING; MEDICATION ERRORS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 79955630025     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1P599     Document Type: Article

References (22)

1. Palella JF Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998;338: 853-60. DOI 10.1056/NEJM.1998.0326.338.1301
2. Detels R, Munoz A, McFarlane G, et al. Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. Multicenter AIDS Cohort Investigators. JAMA 1998;280: 1497-1503. DOI 10.1001/jama.280.17.1497
3. Karon JM, Fleming PL, Steketee RW, De Cock KM. HIV in the United States at the turn of the century: an epidemic in transition. Am J Public Health 2001;91:1060-8. DOI 10.2105/AJPH.91.7.1069
4. Vittghoff E, Scheer S, O'Malley P, et al. Combination antiretroviral therapy and recent declines in AIDS incidence and mortality. J Infect Dis 1999;179:717-20. DOI 10.1086/314623
5. Purdy BD, Raymond AM, Lesar TS. Antiretroviral prescribing errors in hospitalized patients. Ann Pharmacother 2000;34:833-8. DOI 10.1345/aph.19399
6. Garey KW, Teichner P. Pharmacist intervention program for hospitalized patients with HIV infection. Am J Health Syst Pharm 2000;57:2283-4. www. ajhp.org/cgi/reprint/57/24/2283?ijkey=bd3eb445eb5190b4f7d0c3a516ed0b3eb4 99db94&keytype2=tf_ipsecsha
7. Pastakia SD, Corbett AH, Raasch RH, Napravnik S, Correll TA. Frequency of HIV-related medication errors and associated risk factors in hospitalized patients. Ann Pharmacother 2008;42:491-7. DOI 10.1345/aph.1K547
8. Rastegar DA, Knight AM, Monolakis JS. Antiretroviral medication errors among hospitalized patients with HIV infection. Clin Infect Dis 2006;43:933-8. DOI 10.1086/507538
9. Davis Ninno S, Ninno MA. Pharmacotherapy self-assessment program: adverse drug events. 4th ed. American College of Pharmacy 2001:125.
10. Department of Health and Human Services (DHHS) HIV/AIDs most upto-date treatment guidelines 2004. www. aidsinfo.nih.gov/ (accessed 2011 Mar 31)
11. Department of Health and Human Services (DHHS) HIV/AIDs OI prophylaxis and OI treatment guidelines 2003. www. aidsinfo.nih.gov/ (accessed 2011 Mar 31)
12. Liverpool HIV Pharmacology Group (LHPG). The University of Liverpool. www. hiv-druginteractions.org/ (accessed 2011 Mar 31)
13. Smith WD, Winterstein AG, Johns T, et al. Causes of hyperglycemia and hypoglycemia in adult inpatients. Am J Health Syst Pharm 2005;62:714-9. www. ajhp.org/cgi/content/abstract/62/7/714
14. Kanjanarat P, Winterstein AG, Johns TE, et al. The nature of preventable adverse drug events in hospitals: a literature review. Am J Health Syst Pharm 2003;60:1750. www. ajhp.org/cgi/content/abstract/60/17/1750
15. Bates DW, Cullen DJ, Laird N, et al. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group. JAMA 1995;274:29-34. DOI 10.1001/jama.280.20.1741
16. Florida/Caribbean AIDS Education and Training Center (AETC) pocketguide. www. faetc.org/Treatment/ (accessed 2011 Mar 31)
17. Jha AK, Kuperman GJ, Teich JM, et al. Identifying adverse drug events: development of a computer-based monitor and comparison with chart review and stimulated voluntary report. J Am Med Inform Assoc 1998; 5:305-14. DOI 10.1136/jamia.1998.0050305
18. Winterstein AG, Sauer BC, Hepler CD, Poole C. Preventable drug-related hospital admissions. Ann Pharmacother 2002;36:1238-48. DOI 10.1345/aph.1A225
19. Cornish PL, Knowles SR, Marchesanor R, et al. Unintended medication discrepancies at the time of hospital admission. Arch Intern Med 2005; 165:424-9. http://archinte.ama-assn.org/cgi/content/full/165/4/424
20. Foisy MM, Akai PS. Pharmaceutical care for HIV patients on directly observed therapy. Ann Pharmacother 2004;38:550-6. DOI 10.1345/aph.1D444
21. Winterstein AG, John TE, Rosenberg EI, et al. Nature and causes of clinically significant medication errors in a tertiary care hospital. Am Health Syst Pharm 2004;61:1908-16. www. ajhp.org/cgi/content/abstract/61/18/1908
22. To err is human: building a safer health system. Institute of Medicine (IOM) Report 1999. www. iom.edu/Reports/1999/To-Err-is-Human-Building-A-Safer-Health-System.aspx (accessed 2011 Mar 31)